6.
Magee M, Salindri A, Kyaw N, Auld S, Haw J, Umpierrez G
. Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications. Curr Diab Rep. 2018; 18(9):71.
PMC: 6309553.
DOI: 10.1007/s11892-018-1036-y.
View
7.
Jeon C, Murray M
. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008; 5(7):e152.
PMC: 2459204.
DOI: 10.1371/journal.pmed.0050152.
View
8.
Almeida-Junior J, Gil-Santana L, Oliveira C, Castro S, Cafezeiro A, Daltro C
. Glucose Metabolism Disorder Is Associated with Pulmonary Tuberculosis in Individuals with Respiratory Symptoms from Brazil. PLoS One. 2016; 11(4):e0153590.
PMC: 4831681.
DOI: 10.1371/journal.pone.0153590.
View
9.
Hossain M, Ahmed J, Rahim M, Musa A, Latif Z
. Bangladesh national guidelines on the management of tuberculosis and diabetes mellitus co-morbidity (summary). Indian J Endocrinol Metab. 2016; 20(6):853-857.
PMC: 5105572.
DOI: 10.4103/2230-8210.192898.
View
10.
Aftab H, Ambreen A, Jamil M, Garred P, Petersen J, Nielsen S
. Comparative study of HbA and fasting plasma glucose vs the oral glucose tolerance test for diagnosis of diabetes in people with tuberculosis. Diabet Med. 2017; 34(6):800-803.
DOI: 10.1111/dme.13354.
View
11.
Dungan K, Braithwaite S, Preiser J
. Stress hyperglycaemia. Lancet. 2009; 373(9677):1798-807.
PMC: 3144755.
DOI: 10.1016/S0140-6736(09)60553-5.
View
12.
Aftab H, Christensen D, Ambreen A, Jamil M, Garred P, Petersen J
. Tuberculosis-Related Diabetes: Is It Reversible after Complete Treatment?. Am J Trop Med Hyg. 2017; 97(4):1099-1102.
PMC: 5637588.
DOI: 10.4269/ajtmh.16-0816.
View
13.
Li L, Lin Y, Mi F, Tan S, Liang B, Guo C
. Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health. 2012; 17(10):1294-301.
DOI: 10.1111/j.1365-3156.2012.03068.x.
View
14.
Zhou X, Pang Z, Gao W, Wang S, Zhang L, Ning F
. Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China. Diabetes Care. 2009; 33(3):545-50.
PMC: 2827505.
DOI: 10.2337/dc09-1410.
View
15.
Kumar N, Fukutani K, Shruthi B, Alves T, Silveira-Mattos P, Rocha M
. Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity. Elife. 2019; 8.
PMC: 6660216.
DOI: 10.7554/eLife.46477.
View
16.
Jawad F, Shera A, Memon R, Ansari G
. Glucose intolerance in pulmonary tuberculosis. J Pak Med Assoc. 1995; 45(9):237-8.
View
17.
Boillat-Blanco N, Ramaiya K, Mganga M, Minja L, Bovet P, Schindler C
. Transient Hyperglycemia in Patients With Tuberculosis in Tanzania: Implications for Diabetes Screening Algorithms. J Infect Dis. 2015; 213(7):1163-72.
DOI: 10.1093/infdis/jiv568.
View
18.
Koya S, Lordson J, Khan S, Kumar B, Grace C, Nayar K
. Tuberculosis and Diabetes in India: Stakeholder Perspectives on Health System Challenges and Opportunities for Integrated Care. J Epidemiol Glob Health. 2022; 12(1):104-112.
PMC: 8907360.
DOI: 10.1007/s44197-021-00025-1.
View
19.
Lee E, Lee J, Kang Y, Leem A, Kim E, Jung J
. Prevalence and Impact of Diabetes Mellitus Among Patients with Active Pulmonary Tuberculosis in South Korea. Lung. 2017; 195(2):209-215.
DOI: 10.1007/s00408-017-9978-4.
View
20.
Zhou Z, Sun B, Huang S, Zhu C, Bian M
. Glycemic variability: adverse clinical outcomes and how to improve it?. Cardiovasc Diabetol. 2020; 19(1):102.
PMC: 7335439.
DOI: 10.1186/s12933-020-01085-6.
View